These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 33529452)

  • 1. Characteristics of B lymphocyte infiltration in HPV
    Zhang S; Wang B; Ma F; Tong F; Yan B; Liu T; Xie H; Song L; Yu S; Wei L
    Cancer Sci; 2021 Apr; 112(4):1402-1416. PubMed ID: 33529452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I conventional dendritic cells and CD8
    Kirchner J; Plesca I; Rothe R; Resag A; Löck S; Benešová I; Rupp L; Linge A; Wehner R; Krause M; Schmitz M
    Front Immunol; 2024; 15():1414298. PubMed ID: 38938577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
    Gui S; O'Neill WQ; Teknos TN; Pan Q
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
    Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
    J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.
    Wood O; Woo J; Seumois G; Savelyeva N; McCann KJ; Singh D; Jones T; Peel L; Breen MS; Ward M; Garrido Martin E; Sanchez-Elsner T; Thomas G; Vijayanand P; Woelk CH; King E; Ottensmeier C;
    Oncotarget; 2016 Aug; 7(35):56781-56797. PubMed ID: 27462861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination Expectations in HNSCC.
    Syrjänen S; Rautava J
    Recent Results Cancer Res; 2017; 206():257-267. PubMed ID: 27699546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV Meets APOBEC: New Players in Head and Neck Cancer.
    Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
    Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
    Front Immunol; 2021; 12():645170. PubMed ID: 33897693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.
    Cillo AR; Kürten CHL; Tabib T; Qi Z; Onkar S; Wang T; Liu A; Duvvuri U; Kim S; Soose RJ; Oesterreich S; Chen W; Lafyatis R; Bruno TC; Ferris RL; Vignali DAA
    Immunity; 2020 Jan; 52(1):183-199.e9. PubMed ID: 31924475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
    J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
    Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
    Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Tumor Antigen-specific T-cell Responses by Immune Checkpoint Blockade in Human Papillomavirus-related Head and Neck Squamous Cell Carcinoma.
    Chikamatsu K; Ida S; Masuda K; Horikawa M; Hoshino N; Takahashi H; Tada H; Oyama T; Takeda S; Tomidokoro Y; Motegi M
    Anticancer Res; 2024 Jul; 44(7):2921-2931. PubMed ID: 38925841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
    Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
    Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
    Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
    Front Immunol; 2021; 12():652054. PubMed ID: 34305889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
    Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
    Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
    Zeng H; Song X; Ji J; Chen L; Liao Q; Ma X
    BMC Cancer; 2020 Aug; 20(1):796. PubMed ID: 32831060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
    Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
    Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.